Munafa Stock Market Course + Intraday & FNO calls 
RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA
Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY
Dr. Reddy's Laboratories Ltd RDY listed on USA and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Dr. Reddy's Laboratories Ltd RDY
HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26
The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglutide. This decision comes amidst a patent infringement case filed by Novo Nordisk. Dr Reddy's is restricted from selli
Announcement as on 03 December 2025
Stocks in news: Dr Reddy's, GAIL, Hudco, HUL, Acme Solar
Indian markets experienced a subdued trading session, closing nearly half a percent lower due to global uncertainties and continued FII selling. With the monthly expiry approaching, volatility is expected to remain high. Investors are advised to maintain a
Announcement as on 25 November 2025
Dr Reddy's gets European nod for biosimilar to treat osteoporosis
Prolia is a prescription medicine used to treat osteoporosis in women who have been through menopause and in men who are at increased risk of fractures, bone loss linked to hormone ablation in men with prostate cancer at increased risk of fractures and bon
Announcement as on 24 November 2025
Policymakers-industry collaboration vital for healthcare delivery: Dr Reddy's
Dr Reddy's Laboratories chairman Satish Reddy emphasized the need for collaboration between government and industry. This partnership is crucial for creating a healthcare system ready for the future. Reddy shared his views at a pre-budget consultation in N
Announcement as on 24 November 2025
Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across Europe
Dr. Reddy's Laboratories has secured European Commission marketing approval for AVT03, a biosimilar to Prolia and Xgeva, used for bone-related conditions. This authorization permits commercial launch across EU member states, Iceland, Liechtenstein, and Nor
Announcement as on 24 November 2025
Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |
RDY Dr. Reddy's Laboratories Ltd current price & indicator signals
Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 06 Fri Feb 2026 | 14.08 | 13.84 to 14.14 | 0.79% | 1.34 times |
| 05 Thu Feb 2026 | 13.97 | 13.87 to 14.11 | -0.21% | 1.3 times |
| 04 Wed Feb 2026 | 14.00 | 13.75 to 14.06 | 1.38% | 1.17 times |
| 03 Tue Feb 2026 | 13.81 | 13.65 to 13.88 | 1.47% | 1.68 times |
| 02 Mon Feb 2026 | 13.61 | 12.95 to 13.62 | 1.42% | 1.36 times |
| 30 Fri Jan 2026 | 13.42 | 13.26 to 13.47 | 1.13% | 0.76 times |
| 29 Thu Jan 2026 | 13.27 | 13.13 to 13.31 | -0.38% | 0.92 times |
| 28 Wed Jan 2026 | 13.32 | 13.31 to 13.45 | -2.84% | 0.52 times |
| 27 Tue Jan 2026 | 13.71 | 13.64 to 13.80 | -0.51% | 0.74 times |
| 26 Mon Jan 2026 | 13.78 | 13.59 to 13.85 | 0.73% | 0.69 times |
| 23 Fri Jan 2026 | 13.68 | 13.52 to 13.80 | -0.22% | 0.85 times |
| 22 Thu Jan 2026 | 13.71 | 13.36 to 13.95 | 3.24% | 1.9 times |
Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
